Page last updated: 2024-12-04
12-methoxydodecanoate
Description
12-Methoxydodecanoate is a long-chain fatty acid with a methoxy group at the 12th carbon position. It's not a widely known compound, and there's limited information available about its specific applications or importance in research.
However, based on its chemical structure, we can make some assumptions about its potential applications and significance:
**Potential Applications:**
* **Surfactant:** The long hydrophobic tail and polar methoxy head group suggest that 12-methoxydodecanoate could act as a surfactant. Surfactants are crucial in many industries, including detergents, cosmetics, and pharmaceuticals, for their ability to reduce surface tension and improve the mixing of liquids.
* **Bioactive Molecule:** The presence of the methoxy group might confer some bioactivity to the compound. It could potentially interact with biological membranes or receptors, leading to various physiological effects.
* **Building Block for Synthesis:** Due to its relatively simple structure, 12-methoxydodecanoate could be a valuable building block for the synthesis of more complex molecules with specific biological activities.
**Importance for Research:**
* **Understanding Surfactant Properties:** Researchers could investigate its surfactant properties, such as critical micelle concentration (CMC), surface tension reduction, and foaming ability. This would help determine its potential applications in various industries.
* **Bioactivity and Pharmacology:** Studying the interaction of 12-methoxydodecanoate with biological systems could reveal its potential as a drug candidate or a tool for studying cellular processes.
* **Synthesis and Material Science:** Researchers could explore its use as a starting material for the synthesis of novel polymers, coatings, or other materials with tailored properties.
**Overall, 12-methoxydodecanoate presents an intriguing chemical entity with potential applications in various research areas.** Further investigation is needed to determine its specific properties and applications in more detail.
12-methoxydodecanoate: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 1420 |
| CHEMBL ID | 1606365 |
| SCHEMBL ID | 7199372 |
| MeSH ID | M0186063 |
Synonyms (46)
| Synonym |
|---|
| CBIOL_002026 |
| 12-methoxydodecanoate |
| nsc-666070 |
| BIO1_000801 |
| BIO2_000043 |
| BIO2_000523 |
| BIO1_001290 |
| BIO1_000312 |
| IDI1_033793 |
| BSPBIO_001323 |
| 13-oxatetradecanoic acid |
| 13-oxamyr |
| 92169-28-3 |
| 13-oxamyristic acid |
| nsc666070 |
| 12mo |
| 12-methoxydodecanoic acid |
| NCGC00161357-02 |
| NCGC00161357-01 |
| KBIOGR_000043 |
| KBIO2_000043 |
| KBIO3_000086 |
| KBIOSS_000043 |
| KBIO2_005179 |
| KBIO2_002611 |
| KBIO3_000085 |
| NCGC00161357-03 |
| HMS1989C05 |
| BML3-C08 |
| HMS1791C05 |
| HMS1361C05 |
| dodecanoic acid, 12-methoxy- |
| unii-t5d2p5p2a8 |
| t5d2p5p2a8 , |
| nsc 666070 |
| FT-0642222 |
| SCHEMBL7199372 |
| 12-(methoxy)dodecanoic acid |
| OGLQEYICTWWJQB-UHFFFAOYSA-N |
| CHEMBL1606365 |
| HMS3402C05 |
| dodecanoic acid,12-methoxy- |
| DTXSID20238909 |
| 7ut , |
| 12-methoxylauric acid |
| 2-bromo-4-mercaptobenzoicacid |
Protein Targets (1)
Potency Measurements
Bioassays (4)
| Assay ID | Title | Year | Journal | Article |
|---|
| AID1347154 | Primary screen GU AMC qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4
| A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3
| High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.70
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.70 (24.57) | | Research Supply Index | 2.08 (2.92) | | Research Growth Index | 4.78 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |